International Journal of Endocrinology / 2014 / Article / Tab 2

Research Article

Dipeptidyl Peptidase-4 Inhibitors as a Third-Line Oral Antihyperglycaemic Agent in Patients with Type 2 Diabetes Mellitus: The Impact of Ethnicity

Table 2

Changes in HbA1c: pre- versus posttriple therapy.

Subgroups Mean change in HbA1c from baseline (%)Test statistics

Baseline HbA1c
 <8% ()−0.64;
 8-9% () −1.12
 >9% () −2.10
Obesity*
 No ()−1.18;
 Yes () −0.96
Age
 <65 years ()−1.25;
 ≥65 years () −0.82
Gender
 Male ()−1.05;
 Female () −1.15
Diabetes duration
 <10 years ()−1.18;
 10–20 years ()−1.00
 >20 years () −1.20
Duration on triple therapy
 <6 months ()−1.19;
 ≥6 months () −0.85

*Obese in Asians: BMI ≥ 28 kg/m2; obese in non-Asians: BMI ≥ 30 kg/m2.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.